Literature DB >> 16650807

The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.

Piotr Hadaczek1, Yoji Yamashita, Hanna Mirek, Laszlo Tamas, Martha C Bohn, Charles Noble, John W Park, Krystof Bankiewicz.   

Abstract

We investigated the movement of interstitially infused macromolecules within the central nervous system (CNS) in rats with high and low blood pressure (BP)/heart rate and in rats euthanized immediately before infusion (no heart action). Adeno-associated virus 2 (AAV2), fluorescent liposomes, or bovine serum albumin was infused into rat striatum (six hemispheres per group) by convection-enhanced delivery (CED). After infusion, distribution volumes were evaluated. The rats with high BP/heart rate displayed a significantly larger distribution of the infused molecules within the injected site and more extensive transport of those molecules to the globus pallidus. This difference was particularly apparent for AAV2, for which a 16.5-fold greater distribution of viral capsids was observed in the rats with high BP/heart rate than in the rats with no heartbeat. Similar results were observed for liposomes, despite their larger diameter. The distribution of all infused molecules in all rats that had low or no blood flow was confined to the space around brain blood vessels. These findings show that fluid circulation within the CNS through the perivascular space is the primary mechanism by which viral particles and other therapeutic agents administered by CED are spread within the brain and that cardiac contractions power this process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650807      PMCID: PMC2730223          DOI: 10.1016/j.ymthe.2006.02.018

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  43 in total

1.  Targeted retrograde gene delivery for neuronal protection.

Authors:  Brian K Kaspar; Dawn Erickson; David Schaffer; Linda Hinh; Fred H Gage; Daniel A Peterson
Journal:  Mol Ther       Date:  2002-01       Impact factor: 11.454

2.  Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors.

Authors:  Sergei Zolotukhin; Mark Potter; Irene Zolotukhin; Yoshihisa Sakai; Scott Loiler; Thomas J Fraites; Vince A Chiodo; Tina Phillipsberg; Nicholas Muzyczka; William W Hauswirth; Terance R Flotte; Barry J Byrne; Richard O Snyder
Journal:  Methods       Date:  2002-10       Impact factor: 3.608

3.  Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain.

Authors:  J B Nguyen; R Sanchez-Pernaute; J Cunningham; K S Bankiewicz
Journal:  Neuroreport       Date:  2001-07-03       Impact factor: 1.837

4.  In vivo PET imaging of gene expression in Parkinsonian monkeys.

Authors:  J L Eberling; J Cunningham; P Pivirotto; J Bringas; M M Daadi; K S Bankiewicz
Journal:  Mol Ther       Date:  2003-12       Impact factor: 11.454

Review 5.  Recent advances in the use of neurotropic viruses for circuit analysis.

Authors:  Lynn W Enquist; J Patrick Card
Journal:  Curr Opin Neurobiol       Date:  2003-10       Impact factor: 6.627

6.  Arterial pulsation-driven cerebrospinal fluid flow in the perivascular space: a computational model.

Authors:  Lynne E Bilston; David F Fletcher; Andrew R Brodbelt; Marcus A Stoodley
Journal:  Comput Methods Biomech Biomed Engin       Date:  2003-08       Impact factor: 1.763

7.  Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain.

Authors:  S D Preston; P V Steart; A Wilkinson; J A R Nicoll; R O Weller
Journal:  Neuropathol Appl Neurobiol       Date:  2003-04       Impact factor: 8.090

8.  Continuous low-dose treatment with brain-derived neurotrophic factor or neurotrophin-3 protects striatal medium spiny neurons from mild neonatal hypoxia/ischemia: a stereological study.

Authors:  K A Galvin; D E Oorschot
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography.

Authors:  Nikola Kaludov; Beverly Handelman; John A Chiorini
Journal:  Hum Gene Ther       Date:  2002-07-01       Impact factor: 5.695

10.  Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks.

Authors:  Marlon R Veldwijk; Julian Topaly; Stephanie Laufs; Ulrich R Hengge; Frederik Wenz; W Jens Zeller; Stefan Fruehauf
Journal:  Mol Ther       Date:  2002-08       Impact factor: 11.454

View more
  116 in total

1.  AAV provides an alternative for gene therapy of the peripheral sensory nervous system.

Authors:  Andreas S Beutler
Journal:  Mol Ther       Date:  2010-04       Impact factor: 11.454

2.  Ultra-fast magnetic resonance encephalography of physiological brain activity - Glymphatic pulsation mechanisms?

Authors:  Vesa Kiviniemi; Xindi Wang; Vesa Korhonen; Tuija Keinänen; Timo Tuovinen; Joonas Autio; Pierre LeVan; Shella Keilholz; Yu-Feng Zang; Jürgen Hennig; Maiken Nedergaard
Journal:  J Cereb Blood Flow Metab       Date:  2015-12-21       Impact factor: 6.200

Review 3.  Real-time imaging and quantification of brain delivery of liposomes.

Authors:  Michal T Krauze; John Forsayeth; John W Park; Krystof S Bankiewicz
Journal:  Pharm Res       Date:  2006-09-14       Impact factor: 4.200

4.  Real-time imaging of perivascular transport of nanoparticles during convection-enhanced delivery in the rat cortex.

Authors:  Conor P Foley; Nozomi Nishimura; Keith B Neeves; Chris B Schaffer; William L Olbricht
Journal:  Ann Biomed Eng       Date:  2011-10-19       Impact factor: 3.934

5.  Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective.

Authors:  Michal T Krauze; Scott R Vandenberg; Yoji Yamashita; Ryuta Saito; John Forsayeth; Charles Noble; John Park; Krystof S Bankiewicz
Journal:  Exp Neurol       Date:  2007-12-27       Impact factor: 5.330

6.  Real-time MR imaging of adeno-associated viral vector delivery to the primate brain.

Authors:  Massimo S Fiandaca; Vanja Varenika; Jamie Eberling; Tracy McKnight; John Bringas; Phillip Pivirotto; Janine Beyer; Piotr Hadaczek; William Bowers; John Park; Howard Federoff; John Forsayeth; Krystof S Bankiewicz
Journal:  Neuroimage       Date:  2008-11-27       Impact factor: 6.556

Review 7.  Gene therapy for misfolding protein diseases of the central nervous system.

Authors:  Waldy San Sebastian; Lluis Samaranch; Adrian P Kells; John Forsayeth; Krystof S Bankiewicz
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

8.  Combining glial cell line-derived neurotrophic factor gene delivery (AdGDNF) with L-arginine decreases contusion size but not behavioral deficits after traumatic brain injury.

Authors:  M L Degeorge; D Marlowe; E Werner; K E Soderstrom; M Stock; A Mueller; M C Bohn; D A Kozlowski
Journal:  Brain Res       Date:  2011-06-02       Impact factor: 3.252

9.  Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response.

Authors:  Piotr Hadaczek; John Forsayeth; Hanna Mirek; Keith Munson; John Bringas; Phil Pivirotto; Jodi L McBride; Beverly L Davidson; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2009-03       Impact factor: 5.695

10.  The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review.

Authors:  Jan G Veening; Henk P Barendregt
Journal:  Cerebrospinal Fluid Res       Date:  2010-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.